EAST.H — EastWest Bioscience Income Statement
0.000.00%
Last trade - 00:00Consumer CyclicalsHighly SpeculativeMicro Cap
Annual income statement for EastWest Bioscience, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 1.31 | 1.06 |
| Cost of Revenue | ||
| Gross Profit | 0.612 | 0.578 |
| Selling / General / Administrative Expenses | ||
| Research And Development | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 2.26 | 2.81 |
| Operating Profit | -0.958 | -1.76 |
| Gain / Loss on Sale of Assets | ||
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -1.13 | -1.63 |
| Net Income After Taxes | -1.13 | -1.63 |
| Minority Interest | ||
| Net Income Before Extraordinary Items | ||
| Net Income | -1.13 | -1.61 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -1.13 | -1.61 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.02 | -0.018 |